Drug intelligence / Profile preview

Isifera Plus

Development stage
Unknown
Lead developer
Isifer
Modality
Small Molecules
Administration
Vaginal
01

Overview

Isifera Plus is a lidocaine-containing pharmaceutical solution developed by Isifer AB for use in preovulatory pertubation (tubal flushing) as a treatment for couples with unexplained infertility. The active ingredient, lidocaine, is a local anesthetic of the amide type that acts as a sodium channel blocker. Administered via pertubation prior to intrauterine insemination (IUI), Isifera Plus is designed to increase pregnancy rates, potentially through mechanical flushing of the fallopian tubes combined with the anti-inflammatory and membrane-stabilizing effects of lidocaine, which may inhibit sperm phagocytosis. The drug has been evaluated in Phase II clinical trials.

Brand names
Isifera PlusIsifera
02

Targets

NaV (Voltage-gated sodium channels)KCNH2 (Voltage-gated potassium channel subfamily H member 2)LTCC (Voltage-gated calcium channel (L-type))

Beyond the preview

Go deeper on Isifera Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Isifera Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call